This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) | MicrobiomeTrials
← Back to trials NCT07293351
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-03-26Est. Completion: 2029-11-28
Enrollment target: 474 participantsLocations Local Institution - 0178, Palo Alto, California, United States Local Institution - 0117, New Haven, Connecticut, United States Sibley Memorial Hospital, Washington D.C., District of Columbia, United States Local Institution - 0177, Miami, Florida, United States Local Institution - 0126, Orlando, Florida, United States Local Institution - 0170, Fort Wayne, Indiana, United States University Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States Johns Hopkins Hospital, Baltimore, Maryland, United States Local Institution - 0176, Big Rapids, Michigan, United States Washington University School of Medicine, St Louis, Missouri, United States Memorial Sloan Kettering Cancer Center, New York, New York, United States Local Institution - 0135, Cincinnati, Ohio, United States Cleveland Clinic, Cleveland, Ohio, United States MUSC Hollings Cancer Center, Charleston, South Carolina, United States Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States Local Institution - 0158, Salt Lake City, Utah, United States Other microbiome trials you might be interested in Metastatic Clear Cell Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma
The purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is gi…
Gilbert, United States Est. completion Apr 2028
Clear Cell Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7
This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients …
Fairbanks, United States Est. completion Jul 17, 2018
Local Institution - 0095, Seattle, Washington, United States
Asociación de Beneficencia Hospital Sirio Libanés, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Instituto Medico Especializado Alexander Fleming, Buenos Aires, Argentina
Local Institution - 0156, Buenos Aires, Argentina
Macquarie University, North Ryde, New South Wales, Australia
GenesisCare St Leonards, St Leonards, New South Wales, Australia
Mater Misericordiae Limited, Brisbane, Queensland, Australia
Local Institution - 0011, Herston, Queensland, Australia
Local Institution - 0004, Heidelberg, Victoria, Australia
Cabrini Hospital - Malvern, Malvern, Victoria, Australia
Local Institution - 0007, Calgary, Alberta, Canada
Local Institution - 0189, Edmonton, Alberta, Canada
Local Institution - 0109, Montreal, Quebec, Canada
Local Institution - 0009, Montreal, Quebec, Canada
Local Institution - 0006, Québec, Quebec, Canada
Local Institution - 0105, Santiago, Santiago Metropolitan, Chile
Bradfordhill, Santiago, Santiago Metropolitan, Chile
Pontificia Universidad Catolica de Chile (PUC), Santiago, Chile
Local Institution - 0143, Beijing, Beijing Municipality, China
Local Institution - 0157, Beijing, Beijing Municipality, China
Local Institution - 0182, Guangzhou, Guangdong, China
Local Institution - 0145, Tianjin, Hebei, China
Local Institution - 0187, Harbin, Heilongjiang, China
Local Institution - 0183, Changsha Shi, Hunan, China
Local Institution - 0184, Nanjing, Jiangsu, China
Local Institution - 0188, Shanghai Shi, Shanghai Municipality, China
Local Institution - 0144, Beijing, China
Local Institution - 0052, Cali, Colombia
Local Institution - 0147, Prague, Praha 5, Czechia
Local Institution - 0149, Brno, Czechia
Local Institution - 0150, Hradec Králové, Czechia
Local Institution - 0044, Helsinki, Etelä-Suomen Lääni, Finland
Local Institution - 0029, Turku, Finland
Local Institution - 0060, Vantaa, Finland
Local Institution - 0083, Lille, Nord, France
Gustave Roussy, Villejuif, Val-de-Marne, France
Local Institution - 0080, Boredeaux, France
Local Institution - 0025, Jena, Thuringia, Germany
Local Institution - 0026, Hamburg, Germany
Local Institution - 0014, Herne, Germany
Klinikum Rechts der Isar der Technischen Universitaet Muenchen, München, Germany
Local Institution - 0059, Dublin, Ireland
Local Institution - 0062, Dublin, Ireland
Local Institution - 0139, Verona, Veneto, Italy
Local Institution - 0073, Milan, Italy
Local Institution - 0087, Napoli Campania, Italy
Local Institution - 0180, Kobe, Hyōgo, Japan
Local Institution - 0179, Shiwa-gun Yahaba-cho, Iwate, Japan
The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
Toyama University Hospital, Toyoma, Toyama, Japan
Kyushu University Hospital, Fukuoka, Japan
Local Institution - 0181, Niigata, Japan
Local Institution - 0046, Monterrey, Nuevo León, Mexico
Local Institution - 0048, Oaxaca City, Mexico
Local Institution - 0122, Puebla City, Mexico
Local Institution - 0049, Tlalpan, Mexico
Local Institution - 0108, Tlalpan, Mexico
Local Institution - 0118, Tlalpan, Mexico
Local Institution - 0103, Cluj-Napoca, Romania
Centrul de Oncologie Sf. Nectarie SRL, Craiova, Romania
Local Institution - 0100, Iași, Romania
Local Institution - 0101, Sibiu, Romania
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0013, Madrid, Spain
Local Institution - 0091, Madrid, Spain
Local Institution - 0043, Seville, Spain
Kantonsspital Graubünden, Chur, Switzerland
HOCH Health Ostschweiz, Sankt Gallen, Switzerland
UniversitätsSpital Zürich, Zurich, Switzerland
Royal Marsden Hospital (Chelsea), London, Kensington and Chelsea, United Kingdom
St Bartholomew's Hospital, London, London, City of, United Kingdom
Local Institution - 0186, Preston, North West, United Kingdom
Addenbrooke's Hospital, Cambridge, United Kingdom
Velindre Cancer Centre, Cardiff, United Kingdom
Local Institution - 0061, Edinburgh, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Royal Marsden Hospital Sutton, Sulton, Surrey, United Kingdom Locally Advanced Clear Cell Renal Cell Carcinoma
The purpose of this study is to compare the safety and effectiveness of two new treatments: belzutifan alone or belzutif…
Melbourne, Australia Est. completion Apr 2029